EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coolen, L.
Right arrow Articles by Vansteenkiste, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coolen, L.
Right arrow Articles by Vansteenkiste, J.

European Journal of Cardio-Thoracic Surgery, Vol 9, 59-64, Copyright © 1995 by European Association for Cardio-thoracic Surgery


ARTICLES

Surgical treatment of small cell lung cancer

L Coolen, A Van den Eeckhout, G Deneffe, M Demedts and J Vansteenkiste
Department of Pneumology, University Hospital Gasthuisberg, University of Leuven, Belgium.

From 1970 till 1989, 30 patients underwent surgical resection for small cell lung cancer (SCLC). The 5-year survival in stage I patients was 31%, in stage II 17% and in stage III the projected 5-year survival was 9%. Among N2 patients there were only 25% survivors after 1 year and none after 2 years. The first group of 15 patients (1970-1979) received no adjuvant chemotherapy in contrast to the second group of 15 patients (1980-1989). The overall 5-year survival for the first group was 13% and the estimated 5-year survival for the second group was 27%. In stage I SCLC, the 5-year survival was 12% and 60%, respectively. These results confirm that surgery may lead to long-term survival in stage I and possibly stage II SCLC, with better prognosis in stage I when adjuvant chemotherapy is added.


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Granetzny, A. Boseila, W. Wagner, G. Krukemeyer, U. Vogt, E. Hecker, O. M. Koch, and F. Klinke
Surgery in the tri-modality treatment of small cell lung cancer. Stage-dependent survival.
Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 212 - 216.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Inoue, S. Miyoshi, T. Yasumitsu, T. Mori, K. Iuchi, H. Maeda, and H. Matsuda
Surgical results for small cell lung cancer based on the new TNM staging system
Ann. Thorac. Surg., November 1, 2000; 70(5): 1615 - 1619.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. Rea, D. Callegaro, A. Favaretto, M. Loy, A. Paccagnella, U. Fantoni, G. Festi, and F. Sartori
Long term results of surgery and chemotherapy in small cell lung cancer
Eur. J. Cardiothorac. Surg., October 1, 1999; 14(4): 398 - 402.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.